A Case of Methotrexate Induced Pneumonitis in a Patient with Rheumatoid Arthritis.
10.4046/trd.2004.57.3.273
- Author:
Chan Seok PARK
1
;
Sang Haak LEE
;
Kon Ho SHIM
;
Wan Uk KIM
;
Sook Young LEE
;
Seok Chan KIM
;
Kwan Hyoung KIM
;
Hwa Sik MOON
;
Jeong Sup SONG
;
Sung Hak PARK
Author Information
1. Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul, Korea. mdlee@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Methotrexate;
Pneumonitis;
Rheumatoid arthritis
- MeSH:
Alveolitis, Extrinsic Allergic;
Arthritis, Rheumatoid*;
Bronchiolitis;
Diagnosis;
Eosinophilia;
Eosinophils;
Giant Cells;
Granuloma;
Humans;
Inflammation;
Lung Diseases, Interstitial;
Methotrexate*;
Pneumonia*;
Thorax
- From:Tuberculosis and Respiratory Diseases
2004;57(3):273-277
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Methotrexate is commonly used in rheumatoid arthritis as an anti-inflammatory agent, but treatment with methotrexate can lead to severe side effects, especially pulmonary complication. Interstitial pneumonitis is one of the most important pulmonary adverse effects of methotrexate and most patient present with a subacute febrile illness and peripheral eosinophilia is seen in about a half of patients. Almost all patients have abnormal chest roentgenograms and bibasilar interstitial infiltration with alveolar pulmonary consolidations is the most characteristic finding. Interstitial inflammation with mononuclear cell infiltration is a characteristic pathologic feature and findings that suggest acute hypersensitivity pneumonitis, such as bronchiolitis, granuloma formation with giant cells, and infiltration with eosinophils are often present. Methotrexate-induced pneumonitis is a potentially life threatening and unpredictable complication but it is difficult to make a definite diagnosis in the absence of high index of clinical suspicion. Early recognition and appropriate management may avoid the serious outcome. Herein we report a case of methotrexate-induced pneumonitis in a patient with rheumatoid arthritis.
